ALPS ADVISORS INC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 83 filers reported holding REVANCE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.20 and the average weighting 1.4%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$1,624,000
+10.8%
65,366
+22.4%
0.01%
+10.0%
Q2 2018$1,466,000
-0.8%
53,414
+11.3%
0.01%
-16.7%
Q1 2018$1,478,000
+20.7%
47,981
+40.0%
0.01%
+50.0%
Q4 2017$1,225,000
+46.5%
34,279
+12.9%
0.01%
+33.3%
Q3 2017$836,000
+16.0%
30,351
+11.1%
0.01%
+20.0%
Q2 2017$721,000
+41.4%
27,324
+11.4%
0.01%
+25.0%
Q1 2017$510,000
-10.1%
24,531
-10.5%
0.00%0.0%
Q4 2016$567,000
-3.7%
27,404
-24.5%
0.00%
-20.0%
Q3 2016$589,000
+8.3%
36,313
-9.2%
0.01%0.0%
Q2 2016$544,000
-1.3%
39,990
+26.7%
0.01%
-16.7%
Q1 2016$551,000
-56.4%
31,559
-14.6%
0.01%
-50.0%
Q4 2015$1,263,000
-88.7%
36,968
-1.4%
0.01%0.0%
Q3 2015$11,154,000
+1369.6%
37,481
+57.9%
0.01%
+100.0%
Q2 2015$759,000
+211.1%
23,738
+101.4%
0.01%
+200.0%
Q1 2015$244,00011,7840.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders